Inclusion Criteria:

- Patient Consent: Informed Consent and informed consent signed and dated by the
patient (or his legal representative) and the professional who has obtained the
consent. Must be delivered before inclusion. This term must be read and explained to
the patient.

- Patients female or male, regardless of race or color.Able to ingest oral medication.

- Patients 30-80 years, with malignancy, clinical stage III or IV on chemo or hormone
therapy.

- Patients who have a Karnofsky level between 60 and 80.

Exclusion Criteria:

- no agreement to sign the Deed of Consent.

- Need for use of parenteral nutrition.

- The need for food supplement already approved.

- Inability to receive the drug orally.

- Participation in another clinical trial involving chemotherapy drugs.

- Women being sexually active, which does not agree to adhere to the contraceptive
methods adopted.

- Women lactating

- Any problem or condition that the investigator in the trial could be harmful to the
patient.